These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 18922928)

  • 41. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
    Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
    Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3.
    Zhao B; Han H; Chen J; Zhang Z; Li S; Fang F; Zheng Q; Ma Y; Zhang J; Wu N; Yang Y
    Cancer Lett; 2014 Jan; 342(1):43-51. PubMed ID: 23981581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene.
    Spinola M; Leoni VP; Galvan A; Korsching E; Conti B; Pastorino U; Ravagnani F; Columbano A; Skaug V; Haugen A; Dragani TA
    Cancer Lett; 2007 Jun; 251(2):311-6. PubMed ID: 17223258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.
    Wagner PL; Perner S; Rickman DS; LaFargue CJ; Kitabayashi N; Johnstone SF; Weir BA; Meyerson M; Altorki NK; Rubin MA
    Am J Clin Pathol; 2009 Oct; 132(4):500-5. PubMed ID: 19762526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-mediated regulation of KRAS in cancer.
    Kim M; Slack FJ
    J Hematol Oncol; 2014 Nov; 7():84. PubMed ID: 25433809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The miR-146a SNP Rs2910164 and miR-155 SNP rs767649 Are Risk Factors for Non-Small Cell Lung Cancer in the Iranian Population.
    Dezfuli NK; Adcock IM; Alipoor SD; Seyfi S; Salimi B; Mafi Golchin M; Dalil Roofchayee N; Varhram M; Mortaz E
    Can Respir J; 2020; 2020():8179415. PubMed ID: 33294082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
    Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
    Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KRAS 3'-UTR variants and stratification of breast-cancer risk.
    Kumar MS; Swanton C
    Lancet Oncol; 2011 Apr; 12(4):318-9. PubMed ID: 21435949
    [No Abstract]   [Full Text] [Related]  

  • 49. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer.
    Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L
    Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between sex hormones regulation-related SNP rs12233719 and lung cancer risk among never-smoking Chinese women.
    Qian Y; Xie L; Li L; Feng T; Zhu T; Wang R; Yang Y; Zhou B; Yu H; Qian B
    Cancer Med; 2021 Mar; 10(5):1880-1888. PubMed ID: 33595913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis.
    Ulusan M; Sen S; Yilmazer R; Dalay N; Demokan S
    Pathol Res Pract; 2022 Nov; 239():154147. PubMed ID: 36228348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
    Gao F; Xiong X; Pan W; Yang X; Zhou C; Yuan Q; Zhou L; Yang M
    PLoS One; 2015; 10(8):e0135647. PubMed ID: 26274820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
    Pharoah PD; Palmieri RT; Ramus SJ; Gayther SA; Andrulis IL; Anton-Culver H; Antonenkova N; Antoniou AC; Goldgar D; ; Beattie MS; Beckmann MW; Birrer MJ; Bogdanova N; Bolton KL; Brewster W; Brooks-Wilson A; Brown R; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Chen YA; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Despierre E; Doherty JA; Dörk T; Dürst M; Eccles DM; Ekici AB; Easton D; ; Fasching PA; de Fazio A; Fenstermacher DA; Flanagan JM; Fridley BL; Friedman E; Gao B; Sinilnikova O; ; Gentry-Maharaj A; Godwin AK; Goode EL; Goodman MT; Gross J; Hansen TV; Harnett P; Rookus M; ; Heikkinen T; Hein R; Høgdall C; Høgdall E; Iversen ES; Jakubowska A; Johnatty SE; Karlan BY; Kauff ND; Kaye SB; Chenevix-Trench G; ; Kelemen LE; Kiemeney LA; Kjaer SK; Lambrechts D; Lapolla JP; Lázaro C; Le ND; Leminen A; Leunen K; Levine DA; Lu Y; Lundvall L; Macgregor S; Marees T; Massuger LF; McLaughlin JR; Menon U; Montagna M; Moysich KB; Narod SA; Nathanson KL; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Osorio A; Paul J; Pearce CL; Phelan CM; Pike MC; Radice P; Rossing MA; Schildkraut JM; Sellers TA; Singer CF; Song H; Stram DO; Sutphen R; Lindblom A; ; Terry KL; Tsai YY; van Altena AM; Vergote I; Vierkant RA; Vitonis AF; Walsh C; Wang-Gohrke S; Wappenschmidt B; Wu AH; Ziogas A; Berchuck A; Risch HA;
    Clin Cancer Res; 2011 Jun; 17(11):3742-50. PubMed ID: 21385923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Rs61764370 polymorphism within let-7 microRNA-binding site with lung cancer in Iranian population.
    Farokhzad N; Hosseini SM; Edalat H; Sadeghi M
    Afr Health Sci; 2020 Sep; 20(3):1299-1303. PubMed ID: 33402978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KRAS-LCS6 genotype as a prognostic marker in early-stage CRC--letter.
    Ryan BM; Robles AI; Harris CC
    Clin Cancer Res; 2012 Jun; 18(12):3487-8; author reply 3489. PubMed ID: 22669132
    [No Abstract]   [Full Text] [Related]  

  • 56. The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.
    Gutiérrez-Malacatt H; Ayala-Sanchez M; Aquino-Ortega X; Dominguez-Rodriguez J; Martinez-Tovar A; Olarte-Carrillo I; Martinez-Hernandez A; C CC; Orozco L; Cordova EJ
    Asian Pac J Cancer Prev; 2016; 17(4):2265-70. PubMed ID: 27221928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of an Association between a Polymorphism in the KRAS 3' Untranslated Region (rs61764370) and Endometriosis in a Large European Case-Control Study.
    D'Hooghe TM; Grechukhina O; Cho S; Fassbender A; O D; Peterse D; Weidhaas J; Taylor HS
    Gynecol Obstet Invest; 2019; 84(6):575-582. PubMed ID: 31185482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905.
    Lee LJ; Ratner E; Uduman M; Winter K; Boeke M; Greven KM; King S; Burke TW; Underhill K; Kim H; Boulware RJ; Yu H; Parkash V; Lu L; Gaffney D; Dicker AP; Weidhaas J
    PLoS One; 2014; 9(4):e94167. PubMed ID: 24732316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
    Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
    J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seizure 6-like (SEZ6L) gene and risk for lung cancer.
    Gorlov IP; Meyer P; Liloglou T; Myles J; Boettger MB; Cassidy A; Girard L; Minna JD; Fischer R; Duffy S; Spitz MR; Haeussinger K; Kammerer S; Cantor C; Dierkesmann R; Field JK; Amos CI
    Cancer Res; 2007 Sep; 67(17):8406-11. PubMed ID: 17804757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.